Keyphrases
Pathogenicity
100%
H7N9 Influenza Virus
100%
Neuraminidase Inhibitors
100%
R292K
100%
Drug Susceptibility Profile
100%
Ribavirin
33%
T-705
33%
Virus
22%
Resistance Level
22%
Cell-based
22%
H7N9
22%
Viral Load
11%
Infected Mice
11%
Fitness Testing
11%
Effective Treatment
11%
Mutant Virus
11%
Resistant Variants
11%
Synergistic Effect
11%
Influenza-like Illness
11%
High Viral Load
11%
Drug Combination
11%
Delayed Onset
11%
Synergism
11%
Symptom Onset
11%
Clinical Evidence
11%
Transmissibility
11%
Zanamivir
11%
Therapeutic Challenges
11%
Plaque Purification
11%
Serial Passage
11%
Oseltamivir
11%
Inhibitor Resistant
11%
Oseltamivir Carboxylate
11%
Competitive Fitness
11%
Peramivir
11%
Lethality
11%
Combination Regimen
11%
Immunology and Microbiology
Pathogenicity
100%
Lineage
100%
Influenza A Virus (H7N9)
100%
Neuraminidase Inhibitor
100%
Drug Sensitivity
100%
Ribavirin
33%
Virus
22%
Viral Load
22%
Wild Type
22%
Viral Disease
11%
Virus Mutant
11%
Synergism
11%
Relenza
11%
Pharmacology, Toxicology and Pharmaceutical Science
Influenza A Virus (H7N9)
100%
Sialidase Inhibitor
100%
Pathogenicity
100%
Ribavirin
33%
Virus Infection
11%
Antiviral Drug
11%
Combination Drug
11%
Synergism
11%
Oseltamivir
11%
4 Acetamido 5 Amino 3 (1 Ethylpropoxy) 1 Cyclohexene 1 Carboxylic Acid
11%
Relenza
11%
Peramivir
11%
Lethality
11%